share_log

JonesTrading Initiates Coverage On Purple Biotech With Buy Rating, Announces Price Target of $8

JonesTrading Initiates Coverage On Purple Biotech With Buy Rating, Announces Price Target of $8

JoneStrading啓動對Purple Biotech的報道,評級爲買入,宣佈目標股價爲8美元
Benzinga ·  2023/07/21 05:13

JonesTrading analyst Catherine Novack initiates coverage on Purple Biotech (NASDAQ:PPBT) with a Buy rating and announces Price Target of $8.

JoneStrading分析師凱瑟琳·諾瓦克開始對Purple Biotech(納斯達克股票代碼:PPBT)進行報道,評級爲買入,並宣佈目標股價爲8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論